Back to News
investment

Best Stock to Buy and Hold Forever: Altria Group vs. Philip Morris International

newsfeedback@fool.com (Justin Pope)
Loading...
4 min read
0 likes
⚡ Quantum Brief
Tobacco giants Altria and Philip Morris face diverging futures as cigarette demand declines, with smoke-free products now critical to long-term viability. Philip Morris leads with 41.5% of sales from alternatives like Iqos and Zyn. Philip Morris aggressively pivoted to smoke-free products, acquiring Swedish Match (Zyn) in 2022 and launching Iqos over a decade ago. Altria lags, still relying on Marlboro cigarettes despite failed ventures like Juul. Altria’s 50-year dividend growth streak masks vulnerability, as its On! nicotine pouches trail Zyn in market share. Regulatory barriers and addiction dynamics sustain profits but won’t offset long-term volume declines. Philip Morris’s international scale and first-mover advantage in heated tobacco position it for growth. Altria’s U.S. focus and slow innovation risk accelerating revenue erosion if smoke-free adoption surges. Investors favor Philip Morris for its diversified portfolio and execution, while Altria’s future hinges on unproven alternatives. Until Altria proves it can compete, Philip Morris remains the safer long-term bet.
AI Audio Summary
0:00 / 0:00
Click to play
Gemini_Generated_Image_5thz005thz005thz.png
Quantum News · Media Library

By Justin Pope – Mar 24, 2026 at 2:50AM ESTKey PointsCigarettes are a remarkably resilient business, but it won't last forever.Philip Morris began developing smoke-free products much earlier, and it shows in the financials.Altria's dependence on Marlboro cigarettes will remain a red flag for the foreseeable future.There hasn't been, and may never be, a more resilient industry than tobacco. Despite smoking rates in the United States peaking many decades ago, the top tobacco stocks are still megacap behemoths that pay and raise shareholder dividends each year. Among them are Altria Group (MO 0.12%) and Philip Morris International (PM +0.14%), former sister companies that sell Marlboro cigarettes in the United States and internationally. The companies have diverged significantly since separating in 2008. Today, emerging smoke-free nicotine products, from oral pouches to vapes, have breathed new life into the industry. But which tobacco giant is the better stock to buy and hold forever? Image source: Getty Images. Smoke-free products will become increasingly important Cigarettes are a unique product due to their addictive properties and the industry's high regulatory barriers. Altria has managed to continuously offset declining cigarette volumes with price increases, eking out modest growth to fund dividend increases. The company is a Dividend King, with more than 50 years of uninterrupted dividend growth. ExpandNYSE: MOAltria GroupToday's Change(-0.12%) $-0.08Current Price$64.39Key Data PointsMarket Cap$108BDay's Range$64.08 - $65.1652wk Range$52.82 - $70.51Volume12KAvg Vol10MGross Margin75.86%Dividend Yield6.46% Philip Morris has enjoyed a large, but lower-margin, international market. One major difference is that it chose to aggressively pursue new products. Philip Morris launched a heated tobacco brand, Iqos, more than a decade ago and acquired Swedish Match, the maker of the leading nicotine salt pouch brand Zyn, in 2022. Smoke-free products now account for 41.5% of Philip Morris's total net sales, while Altria still relies almost entirely on smokable products. What makes Philip Morris the winner Altria's legacy Marlboro brand is resilient to almost the point of embarrassment, so investors shouldn't panic yet. The company still has time to establish itself in the smoke-free space. That said, it still must prove it can do it. Altria failed miserably with its Juul investment, and its On! nicotine pouch brand lags Zyn in the U.S. market. ExpandNYSE: PMPhilip Morris InternationalToday's Change(0.14%) $0.22Current Price$163.33Key Data PointsMarket Cap$254BDay's Range$162.54 - $164.9552wk Range$142.11 - $191.30Volume136KAvg Vol5.3MGross Margin65.23%Dividend Yield3.53% Meanwhile, Philip Morris has a years-long track record of ramping up Iqos in international markets and is rolling it out in the United States. Zyn has faced competition, but remains the industry leader and is growing by leaps and bounds as the broader market for oral nicotine pouches continues to soar. If Altria doesn't make meaningful progress in the next few years with a cigarette alternative, such as a heated tobacco or vaping device, Iqos and other smoke-free products could really start to pressure its cigarette business. If volume declines accelerate, they could quickly turn Altria's business on its head. Right now, Philip Morris has clear competitive advantages in the smoke-free arena, which positions it well for the long term.

Until Altria Group can deliver tangible results outside its core business, it's a no-brainer for investors to buy and hold Philip Morris.Read NextMar 14, 2026 •By Justin PopeWant Safe Dividend Income in 2026 and Beyond? Invest in the Following 2 Ultra-High-Yield StocksMar 3, 2026 •By David Jagielski, CPAShould You Buy Altria Group Stock for Its 6.1%-Yielding Dividend?Mar 3, 2026 •By Brett SchaferWhy Shares of Altria Group Stock Were Rising in FebruaryFeb 23, 2026 •By Reuben Gregg BrewerWhy I Can't Stop Buying These 3 High-Yielding Dividend StocksFeb 21, 2026 •By Reuben Gregg BrewerAltria Stock Is Interesting, but Here's What I'd Buy InsteadFeb 18, 2026 •By Thomas NielThis High‑Yield Dividend Could Make Patient Investors Rich in RetirementAbout the AuthorJustin Pope is a contributing Motley Fool stock market analyst covering information technology, consumer discretionary, consumer staples, and industrials. Prior to The Motley Fool, Justin was a business manager for an industrial company.TMFbeardedFiStocks MentionedAltria GroupNYSE: MO$64.38(-0.15%)-$0.10Philip Morris InternationalNYSE: PM$163.24(+0.08%)+$0.13*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.